Apixaban Impurity 73 | CAS 40345-06-0 - Request Quote
Apixaban Impurity 73
| SZ CAT No: | SZ-A062101 |
| CAS No | 40345-06-0 |
| Mol.F. | C9H9ClN2O3 |
| Mol.Wt. | 228.6 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apixaban Impurity 73 is chemically (Z)-2-Chloro-2-(2-(4-methoxyphenyl)hydrazono)acetic acid. Apixaban Impurity 73 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 73 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 40345-06-0
Purchase 40345-06-0
Order 40345-06-0
Enquire 40345-06-0
price of 40345-06-0
40345-06-0 Supplier
40345-06-0 Manufacturer
40345-06-0 Exporter
buy high quality Apixaban Impurity 73
Purchase Apixaban Impurity 73
Apixaban Impurity 73 suppliers
Apixaban Impurity 73 manufacturers
Apixaban Impurity 73 price
Order Apixaban Impurity 73
Enquire Apixaban Impurity 73
Apixaban Impurity 73 cost
Apixaban Impurity 73 Supplier
Apixaban Impurity 73 Distributor
Apixaban Impurity 73 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 73 for ANDA Filing
Apixaban Impurity 73 for Forced Degradation Studies
Apixaban Impurity 73 Identification Standards
Apixaban Impurity 73 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.